# Localized Effects of PBM and Exogenous NO on CREST Patients Calcinosis Cutis & Raynaud Phenomenon

> **NCT03972566** · — · UNKNOWN · sponsor: **RoseLab Skin Optics Laboratory** · enrollment: 5 (estimated)

## Conditions studied

- CREST Syndrome
- Calcinosis Cutis
- Raynaud Phenomenon

## Interventions

- **DRUG:** INOMAX

## Key facts

- **NCT ID:** NCT03972566
- **Lead sponsor:** RoseLab Skin Optics Laboratory
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-20
- **Primary completion:** 2019-07-01
- **Final completion:** 2019-09-01
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2019-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03972566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03972566, "Localized Effects of PBM and Exogenous NO on CREST Patients Calcinosis Cutis & Raynaud Phenomenon". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03972566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*